Iboga Tree Healing House — Sintra, Portugal

Iboga Tree Healing House is a small-capacity ibogaine clinic located near Sintra, Portugal. The facility accepts a maximum of five guests at a time and provides individual treatment rooms. Portugal's legal framework permits ibogaine administration under medical supervision, and the clinic states it operates with a fully qualified in-house medical doctor alongside nursing staff certified in Advanced Cardiovascular Life Support (ACLS) by the American Heart Association.

What the Clinic Offers

The program runs for six days and five nights, priced at approximately €6,621 (single occupancy, inclusive of VAT), which translates to roughly $7,200–$7,500 USD depending on exchange rates. Conditions the clinic states it works with include:

  • Opioid addiction
  • Cocaine addiction
  • Alcohol addiction
  • Depression
  • PTSD

Medical Infrastructure

The clinic states it conducts cardiac screening prior to treatment and maintains continuous ECG monitoring throughout ibogaine sessions. Ibogaine carries well-documented cardiac risks, including QT interval prolongation, which can lead to potentially fatal arrhythmias. Continuous monitoring and ACLS certification are considered baseline safety requirements by harm-reduction and medical organizations that evaluate ibogaine treatment settings.

No third-party accreditation is listed for this facility. The clinic claims a 100% safety record; this claim cannot be independently verified through publicly available data.

What to Research Before Committing

  1. Verify medical credentials: Request documentation confirming the attending physician's qualifications and the ACLS certifications of nursing staff.
  2. Understand cardiac screening protocols: Ask specifically which pre-treatment tests are conducted — at minimum, an ECG and comprehensive metabolic panel are standard practice.
  3. Clarify aftercare: A six-day program is short; ask what structured aftercare or referral support is provided following discharge, particularly for addiction treatment.
  4. Review contraindications: Ibogaine has significant contraindications with many common medications, including SSRIs and methadone. Disclose all current medications during screening.
  5. Ask about emergency protocols: Confirm the distance to the nearest hospital equipped for cardiac emergencies and how transfer would be managed.
Important: Ibogaine is a Schedule I substance in the United States and is restricted or unregulated in many countries. Its cardiac risks are well-documented and fatalities have occurred in treatment settings globally. Medical supervision does not eliminate risk.